Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

[Meibomian gland dysfunction].

Finis D, Schrader S, Geerling G.

Klin Monbl Augenheilkd. 2012 May;229(5):506-13. doi: 10.1055/s-0031-1299533. Epub 2012 May 16. Review. German.

PMID:
22592341
2.

Disposable eyelid-warming device for the treatment of meibomian gland dysfunction.

Mori A, Shimazaki J, Shimmura S, Fujishima H, Oguchi Y, Tsubota K.

Jpn J Ophthalmol. 2003 Nov-Dec;47(6):578-86.

PMID:
14636848
3.

Evaluation of an automated thermodynamic treatment (LipiFlow®) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial.

Finis D, Hayajneh J, König C, Borrelli M, Schrader S, Geerling G.

Ocul Surf. 2014 Apr;12(2):146-54. doi: 10.1016/j.jtos.2013.12.001. Epub 2014 Jan 22.

PMID:
24725326
4.

Changes in meibomian fatty acids and clinical signs in patients with meibomian gland dysfunction after minocycline treatment.

Souchier M, Joffre C, Grégoire S, Bretillon L, Muselier A, Acar N, Beynat J, Bron A, D'Athis P, Creuzot-Garcher C.

Br J Ophthalmol. 2008 Jun;92(6):819-22. doi: 10.1136/bjo.2007.133900. Epub 2008 May 29.

PMID:
18511542
5.

Conservative treatment of meibomian gland dysfunction.

Romero JM, Biser SA, Perry HD, Levinson DH, Doshi SJ, Terraciano A, Donnenfeld ED.

Eye Contact Lens. 2004 Jan;30(1):14-9.

PMID:
14722463
6.

Minocycline controls clinical outcomes and inflammatory cytokines in moderate and severe meibomian gland dysfunction.

Lee H, Min K, Kim EK, Kim TI.

Am J Ophthalmol. 2012 Dec;154(6):949-957.e1. doi: 10.1016/j.ajo.2012.06.009. Epub 2012 Sep 8.

PMID:
22967863
7.

Meibomian therapy in problematic contact lens wear.

Paugh JR, Knapp LL, Martinson JR, Hom MM.

Optom Vis Sci. 1990 Nov;67(11):803-6.

PMID:
2250886
8.

Eyelid margin modification associated with eyelid hygiene in anterior blepharitis and meibomian gland dysfunction.

Guillon M, Maissa C, Wong S.

Eye Contact Lens. 2012 Sep;38(5):319-25. doi: 10.1097/ICL.0b013e318268305a.

PMID:
22890229
9.

Low-concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunction.

Goto E, Shimazaki J, Monden Y, Takano Y, Yagi Y, Shimmura S, Tsubota K.

Ophthalmology. 2002 Nov;109(11):2030-5.

PMID:
12414410
10.

Effects of Eyelid Warming Devices on Tear Film Parameters in Normal Subjects and Patients with Meibomian Gland Dysfunction.

Arita R, Morishige N, Shirakawa R, Sato Y, Amano S.

Ocul Surf. 2015 Oct;13(4):321-30. doi: 10.1016/j.jtos.2015.04.005. Epub 2015 May 30.

11.

Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study.

Foulks GN, Borchman D, Yappert M, Kakar S.

Cornea. 2013 Jan;32(1):44-53. doi: 10.1097/ICO.0b013e318254205f.

12.

Topical diquafosol for patients with obstructive meibomian gland dysfunction.

Arita R, Suehiro J, Haraguchi T, Maeda S, Maeda K, Tokoro H, Amano S.

Br J Ophthalmol. 2013 Jun;97(6):725-9. doi: 10.1136/bjophthalmol-2012-302668. Epub 2013 Apr 12.

13.

A novel thermodynamic treatment for meibomian gland dysfunction.

Friedland BR, Fleming CP, Blackie CA, Korb DR.

Curr Eye Res. 2011 Feb;36(2):79-87. doi: 10.3109/02713683.2010.509529.

PMID:
21281063
14.

Effect of oral linoleic and gamma-linolenic acid on meibomian gland dysfunction.

Pinna A, Piccinini P, Carta F.

Cornea. 2007 Apr;26(3):260-4.

PMID:
17413949
15.

Efficacy of a new warm moist air device on tear functions of patients with simple meibomian gland dysfunction.

Matsumoto Y, Dogru M, Goto E, Ishida R, Kojima T, Onguchi T, Yagi Y, Shimazaki J, Tsubota K.

Cornea. 2006 Jul;25(6):644-50.

PMID:
17077654
16.

Improving awareness, identification, and management of meibomian gland dysfunction.

Foulks GN, Nichols KK, Bron AJ, Holland EJ, McDonald MB, Nelson JD.

Ophthalmology. 2012 Oct;119(10 Suppl):S1-12. doi: 10.1016/j.ophtha.2012.06.064.

PMID:
23034341
17.

Tear film with "Orgahexa EyeMasks" in patients with meibomian gland dysfunction.

Ishida R, Matsumoto Y, Onguchi T, Kaido M, Iwamuro K, Kobayashi J, Takano Y, Shimazaki J, Goto E, Dogru M, Tsubota K.

Optom Vis Sci. 2008 Aug;85(8):684-91. doi: 10.1097/OPX.0b013e318181ae83.

PMID:
18677224
18.

Proposed diagnostic criteria for seborrheic meibomian gland dysfunction.

Arita R, Itoh K, Maeda S, Maeda K, Furuta A, Tomidokoro A, Amano S.

Cornea. 2010 Sep;29(9):980-4. doi: 10.1097/ICO.0b013e3181cc7b1b.

PMID:
20628302
19.

New therapies in common ocular surface disorders.

Pescosolido N, Parisi F, Buomprisco G, Librando A.

Clin Ter. 2013;164(5):e405-11. doi: 10.7417/CT.2013.1621. Review.

PMID:
24217843
20.

Effects of topical loteprednol etabonate on tear cytokines and clinical outcomes in moderate and severe meibomian gland dysfunction: randomized clinical trial.

Lee H, Chung B, Kim KS, Seo KY, Choi BJ, Kim TI.

Am J Ophthalmol. 2014 Dec;158(6):1172-1183.e1. doi: 10.1016/j.ajo.2014.08.015. Epub 2014 Aug 13.

PMID:
25128594

Supplemental Content

Support Center